speb/financial-data huggingface dataset:
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 9644000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 31655000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -503000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 42000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Other Special Charges: 2680000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 10000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 33619000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 714000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 63000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -319000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -2802000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -7000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -381000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 1082000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 12769000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5304000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2063000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -2016000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -4000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Research And Development: 2319000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -14234000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3569000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 1838138571.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 241000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -2007000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -2680000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 209000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -2642000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -92583000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -567000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 526000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 133898000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 60329000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 68743000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -2599000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 11192000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 136497000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 105359000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 97106000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 1904000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2700000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2700000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 70788693.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 9143000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Work In Process: 2277000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: -10852000000.00
ABBV.TO income_statement (annual, 2025-12-31) — +Operating Expense: 22865000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 6257000000.00
ABBV.TO income_statement (annual, 2025-12-31) — +Total Revenue: 61160000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 16618000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 3592000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3592000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 12589000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 12589000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7902000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7902000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 22495000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 22495000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 7377000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 1784000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 7377000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 1784000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 847000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
ABBV.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 16704505166.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 16704505166.00
ABBV.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.25
ABBV.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.11
ABBV.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 5524000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 5629000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 3057000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 3057000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -1214000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -329000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 18000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 18000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5229000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5229000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5257000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5257000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -11657000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -2911000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -12724000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4166000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -6643000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1463000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 19030000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5218000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 951000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -598000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -234000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -25000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -762000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 646000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Change In Payable: 951000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -598000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 951000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -598000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -827000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -658000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -1490000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 162000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -2362000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -473000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1490000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 162000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -337000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -411000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Common Stock: 18000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 18000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -11657000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -2911000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: -3270000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -3270000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -980000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -3000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 1401000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1401000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 18204000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4552000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 28043000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 28043000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Current Assets: 29062000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 29062000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Current Debt: 8555000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 8555000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 8555000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 8555000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 43289000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 43289000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -492000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -385000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -492000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -385000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Depreciation: 762000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 203000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 8139000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1987000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 8139000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1987000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 16752921060.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 16762369972.00
ABBV.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.25
ABBV.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.11
ABBV.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 4186000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1806000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 3099000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 3099000000.00
ABBV.TO income_statement (annual, 2025-12-31) — EBIT: 9490000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — EBIT: 3382000000.00
ABBV.TO income_statement (annual, 2025-12-31) — EBITDA: 17629000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — EBITDA: 5369000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 42000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 11000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Employee Benefits: 1410000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1410000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — End Cash Position: 5229000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 5229000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -12724000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4166000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 1580000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1580000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 17816000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 4889000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -58000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -11000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1144000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1144000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Goodwill: 35640000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 35640000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 88281000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 88281000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 13530000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 13530000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Gross Profit: 42956000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 12066000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3626000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Interest Expense: 2893000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 714000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2893000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 714000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Interest Income: 266000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Interest Income: 59000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 266000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 59000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3002000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 823000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Inventory: 4951000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 4951000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 64226000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 64226000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -6643000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1463000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 268000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 268000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 9291000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -500000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 287000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 287000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 58941000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 58941000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 58941000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 58941000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3994000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
ABBV.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -6797000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -8000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 42000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 42000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Minority Interests: -7000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Minority Interests: 1000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -5441000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -1161000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -980000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -3000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Net Debt: 62267000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 62267000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Net Income: 4226000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Net Income: 1816000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 4186000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1806000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 4233000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1815000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4226000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1816000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4226000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1816000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 4233000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 1815000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 4233000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1815000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Net Interest Income: -2627000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -655000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 41000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 28000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -304000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1299000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -2803000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -8000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -2627000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -655000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 45000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -29000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Net PPE: 5628000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 5628000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1214000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -329000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 2499000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -1291000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -91551000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -91551000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 2389000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 2389000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2389000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2389000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1410000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1410000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 22703000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 6645000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Normalized Income: 7481758981.36
ABBV.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 2684043478.26
ABBV.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 19030000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 5218000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Operating Income: 20091000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Operating Income: 5809000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Operating Revenue: 61160000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 16618000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1767876035.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1767876035.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 6265000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6265000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1144000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1144000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Other Income Expense: -10867000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -2486000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 52641000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 52641000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 8643000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1981000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 10721000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 10721000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 30795000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 30795000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -5793000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1210000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: -241000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -217000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Other Properties: 8785000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 8785000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 28000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 28000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Other Special Charges: 5016000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Other Special Charges: 1265000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 40000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 10000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Payables: 6691000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Payables: 6691000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 34734000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 34734000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Pretax Income: 6597000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 2668000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 172000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 48000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ABBV.TO cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -933000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 136000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -5441000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -1161000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -35000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -6000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1214000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -329000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 1084000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1084000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Receivables: 12589000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 12589000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 18204000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4552000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 8139000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1987000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -9595000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -799000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -980000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -3000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Research And Development: 9096000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Research And Development: 2579000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -15493000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -15493000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 76000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 34000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 14010000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 3895000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Share Issued: 1838678628.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 1838678628.00
ABBV.TO cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 5297000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: -500000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -2798000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -791000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Special Income Charges: -5016000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -1265000000.00
ABBV.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 955000000.00
ABBV.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 157000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: -3270000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -3270000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: -91551000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -91551000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1818241018.64
ABBV.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -407956521.74
ABBV.TO income_statement (annual, 2025-12-31) — Tax Provision: 2364000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 853000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.36
ABBV.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.32
ABBV.TO balance_sheet (annual, 2025-12-31) — Total Assets: 133960000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 133960000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 55671000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 55671000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Total Debt: 67496000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 67496000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -3228000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -3228000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Total Expenses: 41069000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 10809000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 137188000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 137188000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 104898000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 104898000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 93899000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 93899000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 15075000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 4544000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -5074000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1276000000.00
ABBV.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5074000000.00
ABBV.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1276000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 364000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 364000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 70802593.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 70802593.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Treasury Stock: 9146000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 9146000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Work In Process: 2287000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 2287000000.00
ABBV.TO balance_sheet (annual, 2025-12-31) — Working Capital: -14227000000.00
ABBV.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: -14227000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 6050000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 15002000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 12479000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -8044000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 22962000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 1748000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 1748000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 16693697047.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.04
ABBV.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5229000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -265000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 18000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9391000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9391000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -3086000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 919000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -574000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 3829000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -1594000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -184000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -81000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: -1594000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1594000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -150000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 87000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1922000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 87000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 4174000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 18000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -3086000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -6656000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1489000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4218000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 33529000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 8326000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 8326000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 42100000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 137000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 137000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 188000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1936000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1936000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 16762369972.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.04
ABBV.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 685000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — EBIT: 1756000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — EBITDA: 3692000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -12000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 9391000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 919000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 1806000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3564000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1153000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 35570000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 86443000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 13731000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 10784000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 717000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 717000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Interest Income: 72000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 72000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 5049000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 66202000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -574000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 268000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 7991000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 64532000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 64532000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 7991000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 44000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Minority Interests: -2000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -266000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1489000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 63467000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Net Income: 695000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 685000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 697000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 695000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 695000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 697000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 697000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -645000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 5492000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 7991000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -645000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 2000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -43000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 5687000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -265000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -2499000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -93099000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 2332000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2332000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 4436000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 1194102983.64
ABBV.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 3829000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Operating Income: 4734000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 15002000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1766732187.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 6610000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1153000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: -3050000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 50873000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2537000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 10536000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 34111000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -2306000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Other Special Charges: 744000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 10000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 33774000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 1039000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -266000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -265000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1106000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 12479000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4218000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1936000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -2499000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1489000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Research And Development: 2472000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -17872000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3578000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 1843809386.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -2499000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: -744000000.00
ABBV.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 444000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -6656000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -93099000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -244897016.36
ABBV.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 342000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.33
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 136463000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 57876000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 72858000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -6612000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 10268000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 143075000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 102934000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 100975000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 3990000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -744000000.00
ABBV.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -744000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 77077199.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 10611000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Work In Process: 2137000000.00
ABBV.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: -8571000000.00
ABCA.PA cash_flow (annual, 2021-12-31) — Common Stock Issuance: 1734000.00
ABCA.PA cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 1734000.00
ABCA.PA cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -992000.00
ABCA.PA cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
ABCA.PA cash_flow (annual, 2021-12-31) — Repayment Of Debt: -992000.00
ABCA.PA income_statement (annual, 2022-12-31) — +Operating Expense: 32281000.00
ABCA.PA income_statement (annual, 2022-12-31) — +Total Revenue: 61372000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Accounts Payable: 487000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -7077000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 41441000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 154844000.00
ABCA.PA income_statement (annual, 2022-12-31) — Basic Average Shares: 59137038.00
ABCA.PA income_statement (annual, 2022-12-31) — Basic EPS: 0.49
ABCA.PA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 18252000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 954000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 14226000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 14226000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -23682000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 14226000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -6648000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Change In Working Capital: -6648000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Changes In Cash: -4026000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Common Stock: 954000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -23682000.00
ABCA.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 161655000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1694000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Depreciation: 1756000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1756000.00
ABCA.PA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1691000.00
ABCA.PA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 1691000.00
ABCA.PA income_statement (annual, 2022-12-31) — Diluted Average Shares: 59774563.00
ABCA.PA income_statement (annual, 2022-12-31) — Diluted EPS: 0.49
ABCA.PA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 29150000.00
ABCA.PA cash_flow (annual, 2022-12-31) — End Cash Position: 14226000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Financing Cash Flow: -27473000.00
ABCA.PA cash_flow (annual, 2022-12-31) — Free Cash Flow: 24403000.00
ABCA.PA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 33711000.00
ABCA.PA income_statement (annual, 2022-12-31) — General And Administrative Expense: 7501000.00